Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-05-22

Clinical Trial Update: Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on atomoxetine's effects on nicotine response and stress response in smokers, involving Phase 1 and Phase 2 studies, which has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Yale University | Conditions: Nicotine Dependence | Phase 1, Phase 2 | Status: WITHDRAWN